Advertisement
UK markets closed
  • FTSE 100

    8,164.12
    -15.56 (-0.19%)
     
  • FTSE 250

    20,286.03
    -45.77 (-0.23%)
     
  • AIM

    764.38
    -0.09 (-0.01%)
     
  • GBP/EUR

    1.1796
    -0.0009 (-0.07%)
     
  • GBP/USD

    1.2646
    +0.0005 (+0.04%)
     
  • Bitcoin GBP

    48,597.12
    +447.33 (+0.93%)
     
  • CMC Crypto 200

    1,273.63
    -10.20 (-0.79%)
     
  • S&P 500

    5,460.48
    -22.39 (-0.41%)
     
  • DOW

    39,118.86
    -45.20 (-0.12%)
     
  • CRUDE OIL

    81.46
    -0.28 (-0.34%)
     
  • GOLD FUTURES

    2,336.90
    +0.30 (+0.01%)
     
  • NIKKEI 225

    39,583.08
    +241.54 (+0.61%)
     
  • HANG SENG

    17,718.61
    +2.14 (+0.01%)
     
  • DAX

    18,235.45
    +24.90 (+0.14%)
     
  • CAC 40

    7,479.40
    -51.32 (-0.68%)
     

UPDATE 1-Drugmaker Viatris appoints Theodora Mistras as CFO

(Adds appointment details throughout)

Dec 15 (Reuters) - Global healthcare company Viatris on Friday appointed Theodora Mistras as its chief financial officer, effective March 1.

The company said the current CFO Sanjeev Narula will work closely with Mistras to support a smooth transition and will then depart the company on March 1.

Mistras most recently was the managing director of healthcare investment banking at Citigroup Global Markets and has almost two decades of leadership, advisory and capital markets experience, Viatris said.

The drugmaker also appointed Philippe Martin as chief research and development officer with immediate effect.

ADVERTISEMENT

In October, Viatris

said

it had reached agreements to divest some of its businesses for a total of up to $3.6 billion as part of long-term strategy to streamline focus on three core therapeutic areas - ophthalmology, gastroenterology and dermatology. (Reporting by Christy Santhosh and Granth Vanaik in Bengaluru; Editing by Maju Samuel)